Patents
Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
08/2010
08/12/2010CA2751441A1 Novel herbicides
08/12/2010CA2751440A1 Novel herbicides
08/11/2010CN101239982B Alkaloids compounds with hepatitis virus resisting activity
08/10/2010US7772407 (1S)-1,5-anhydro-1-[3-(1-benzothien-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity
08/10/2010US7772269 Pyrazole analogs
08/10/2010US7772191 Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
08/05/2010WO2010066909A3 New inhibitors for treating diseases associated with an excess transport of hyaluronan
08/05/2010WO2010040843A3 Dibenzocycloheptanone derivatives and pharmaceutical agents containing said compounds
08/05/2010US20100197943 Biodiesel production unit and biodiesel compositions
08/05/2010US20100197735 Novel phenylurea inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof
08/04/2010EP2212286A1 Synthesis of quaternary salt compounds
08/04/2010CN101796194A Large-scale purification method for 2-pyrone-4,6-dicarboxylic acid
08/04/2010CN101791574A Catalyst loaded with chiral imidazolium and preparation method thereof
08/03/2010US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/03/2010US7767277 Fluorophenyl compounds for liquid-crystalline mixtures
08/03/2010US7767249 Preparation of nanoparticles
07/2010
07/29/2010WO2010083732A1 N-acetylneuraminic acid compounds, pharmaceutical composition, preparation method and uses thereof
07/29/2010WO2010063948A3 Novel c-xyloside oxime compounds, and cosmetic use
07/29/2010US20100191003 Method for producing glycoside aglycone
07/29/2010US20100191002 Method of Oxidization Using Nitric Acid
07/28/2010CN101787020A Organic conjugated molecule capable of being processed by solution and application thereof in solar cells
07/28/2010CN101787008A N-acetyl neuraminic acid compounds, medicine compositions thereof and preparation methods and purposes thereof
07/28/2010CN101787006A Method for directional thermal degradation of fiber biomass
07/27/2010CA2463084C Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
07/22/2010WO2010082661A1 1,5-ag-containing composition
07/22/2010WO2010081894A1 Cyclopentadione derived herbicides
07/22/2010WO2010081755A1 Novel herbicides
07/22/2010WO2010061182A3 Process for preparing zanamivir and intermediates for use in the process
07/22/2010US20100185014 Hydroxylation of Beta-Dicarbonyls with Zirconium Catalysts
07/22/2010US20100184999 Methods of performing cycloadditions, reaction mixtures, and methods of performing asymmetric catalytic reactions
07/22/2010US20100183563 Dentinogenesis promoter and dentinogenic pulp-capping material
07/22/2010CA2749615A1 Novel herbicides
07/22/2010CA2749216A1 Cyclopentadione derived herbicides
07/21/2010CN1826310B Novel aminobenzophenone compounds
07/20/2010US7759392 4-nitroxybutyric acid ester derivatives of drugs such as acetaminophen, having an improved therapeutic index (efficacy/toxicity ratio) or a lower risk/benefit ratio, usedfor treating oxidative stress and endothelian dysfunctions, inflammation and pain
07/15/2010WO2010051935A3 Substituted amido phenoxybenzamides
07/15/2010WO2010032988A3 Kojic acid metal complex derivative bonded with amino acid
07/14/2010EP2206695A1 Tetra- or penta-cyclic liquid crystalline compound having lateral fluorine, liquid crystal composition, and liquid crystal display element
07/14/2010EP2021333B1 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof
07/14/2010EP1891026B1 Cycloalkylidene compounds as selective estrogen receptor modulators
07/14/2010CN101775000A Process fot the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof
07/14/2010CN101774989A Preferable method for extracting refined yellow pigment from red flowers
07/08/2010US20100173952 Metalloprotein inhibitors
07/07/2010EP2203434A2 Method of preparing (6r)-3-hexyl-4-hydroxy-6-undecyl-5,6-dihydropyran-2-one, and intermediate used in the method
07/07/2010EP2203051A1 Octahydropentalene compounds as chemokine receptor antagonists
07/07/2010CN1823051B Process for production of 4-aminotetrahydropyrans and salts thereof with acids, intermediates for the process, and process for production thereof
07/01/2010WO2010075280A2 Coumarin-based compounds
07/01/2010WO2010074327A1 Halogen-containing organosulfur compounds and use thereof for controlling arthropod pest
07/01/2010WO2010030395A3 Withaferin a analogs and uses thereof
07/01/2010US20100168160 Genipin Derivatives and Uses Thereof
07/01/2010CA2747811A1 Coumarin-based compounds
06/2010
06/30/2010EP2202293A2 New mutactimycin and aldgamycin active compounds and the use thereof in therapy
06/30/2010EP2201945A2 Substituted 2-Aminoacetamides and the Use Thereof
06/30/2010EP2201944A2 Substituted 2-Aminoacetamides and the Use Thereof
06/30/2010EP1735270B1 Diamino alcohols and their use as renin inhibitors
06/30/2010CN101759677A Preparation method for patchoulenone
06/30/2010CN101759676A Preparation method of novel whitening additive, i.e. kojic acid dipalmitate
06/29/2010US7745649 Processes for preparing tetrahydropyran-4-one and pyran-4-one
06/29/2010US7745489 Potent 2-oxo-amide based compounds; abrogating prostaglandin production; low dosage; spinal cord and central nervous system pain
06/24/2010WO2010070910A1 1-heterodiene derivative and harmful organism control agent
06/24/2010WO2010069979A1 Pyran derivatives as ccr3 modulators
06/24/2010WO2010069593A1 Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
06/24/2010US20100160424 Renin inhibitors
06/24/2010US20100159540 Synthesis of resolvins and intermediates, compounds prepared thereby, and uses thereof
06/24/2010CA2747424A1 1-heterodiene derivative and harmful organism control agent
06/23/2010EP2197271A2 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
06/23/2010EP1280770B1 C 2? phenyl-substituted cyclic keto-enols used as pesticides and herbicides
06/23/2010CN101747362A Method for preparing simvastatin intermediate - simva-acylamide second silicon ether
06/23/2010CN101747357A Method for preparing simvastatin intermediate - simva-acylamide second silicon ether
06/23/2010CN101747304A Method for preparing glycal
06/22/2010US7741497 Processes for preparing alkyl 3-(4-tetrahydropyranyl)-3-oxopropanoate compound and 4-acyltetrahydropyrane
06/22/2010US7741456 Polyketides and antibiotics produced by combinatorial techniques
06/22/2010US7741352 for the treatment or alleviation of pain, headaches, nervous system disorders or trauma, stroke, neurodegenerative diseases, cardiovascular disorders, inflammatory diseases, vision defects, hearing disorders, respiratory system disordres and urinary incontinence
06/22/2010US7741344 resolution of racemic mixture of 6-(bromomethylene)-3-(1-naphthalenyl)-2H-tetrahydropyran-2-one (BEL), using chromatography; enzyme inhibtors used to determining the role of specific isoforms of Calcium-independent phospholipases A2 (iPLA2s)
06/17/2010WO2010067176A1 Maltol ether processes and intermediates
06/17/2010WO2010067036A1 Novel aryl c-xyloside compounds, and cosmetic use
06/17/2010WO2010066909A2 New inhibitors for treating diseases associated with an excess transport of hyaluronan
06/17/2010WO2010022313A3 Processes for the preparation of sglt2 inhibitors
06/17/2010US20100152098 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
06/17/2010US20100152083 Perfume Systems
06/17/2010CA2742920A1 New inhibitors for treating diseases associated with an excess transport of hyaluronan
06/16/2010EP2195307A1 Piperazine derivative having affinity for the histamine h3 receptor
06/16/2010CN1970558B lactic acid base puerarin derivative preparation method
06/16/2010CN1803798B Method for producing fungicide compand
06/15/2010US7737287 Anomeric derivatives of monosaccharides
06/15/2010US7737286 α-Hydroxy-benzeneacetic acid derivatives, and compounds having two 5-membered latone rings fused to central cyclohexa-1,4-diene nucleus based upon the same, and uses of the compounds
06/10/2010WO2010063953A2 Novel amino c-xyloside compounds, and cosmetic use
06/10/2010WO2010063948A2 Novel c-xyloside oxime compounds, and cosmetic use
06/10/2010WO2010063802A1 3, 4-di-substituted cyclobutene- 1, 2 -diones as cxcr2 receptor antagonists
06/10/2010WO2010063773A1 Novel 4-(heterocycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
06/10/2010WO2010063742A1 Method for producing delta valerolactone in the gas phase
06/10/2010US20100145046 Substituted 3-hydroxy-delta-lactones from epoxides
06/10/2010US20100144862 Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
06/10/2010US20100144747 1h-quinaz0line-2,4-diones
06/10/2010US20100144045 Chiral selectors for separating enantiomers of a compound
06/10/2010CA2744711A1 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
06/10/2010CA2744708A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
06/10/2010CA2742703A1 Novel 4- (heterocycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
06/09/2010CN101730688A 2-aryl-5-heterocyclyl-cyclohexane-1,3-dione compounds and their use as herbicides
06/08/2010US7732414 cosmetic make-up removing composition; for treating aging, fibroblasts, keratinocytes; particularly hyaluronic acid, proteoglycans
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 129